HK Stock MarketDetailed Quotes

SINOPHARM (01099)

Watchlist
  • 18.690
  • +0.030+0.16%
Market Closed May 6 16:07 CST
58.33BMarket Cap7.24P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINOPHARM (01099) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2025/FY
Stock NameRevenueRatio
医药分销业务415.31B72.21%
器械分销业务115.18B20.03%
Pharmaceutical retail business37.93B6.60%
Other business6.74B1.17%

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
医药分销业务415.31B72.21%
器械分销业务115.18B20.03%
Pharmaceutical retail business37.93B6.60%
Other business6.74B1.17%

By Country/Region

Currency:CNY
2019/H1
Stock NameRevenueRatio
China201.57B99.95%
Undistributed96.74M0.05%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.45%
Sample Name
Sample Code
 +4.80%
Sample Name
Sample Code
 +3.86%
4
CNOOC
00883
+3.77%
5
SINOPEC CORP
00386
+2.61%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +61.02%
Sample Name
Sample Code
 +51.07%
Sample Name
Sample Code
 +40.94%
4
Business-intelligence Of Oriental Nations Corporation
300166
+33.12%
5
Emdoor Information
001314
+32.98%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -